Brookfield [BN] vs Ameriprise [AMP] Detailed Stock Comparison
Brookfield
NYSE
Loading...
Ameriprise
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Brookfield wins in 6 metrics, Ameriprise wins in 11 metrics, with 0 ties. Ameriprise appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Brookfield | Ameriprise | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 232.59 | 17.70 | Ameriprise |
| Price-to-Book Ratio | 2.46 | 8.08 | Brookfield |
| Debt-to-Equity Ratio | 156.81 | 53.93 | Ameriprise |
| PEG Ratio | 11.49 | 13.48 | Brookfield |
| EV/EBITDA | 14.75 | N/A | N/A |
| Profit Margin (TTM) | 0.73% | 17.74% | Ameriprise |
| Operating Margin (TTM) | 27.05% | 36.30% | Ameriprise |
| EBITDA Margin (TTM) | 27.05% | 36.30% | Ameriprise |
| Return on Equity | 0.95% | 58.24% | Ameriprise |
| Return on Assets (TTM) | 2.69% | 2.20% | Brookfield |
| Free Cash Flow (TTM) | $-3.60B | $6.42B | Ameriprise |
| Dividend Yield | N/A | 0.88% | N/A |
| 1-Year Return | 41.64% | 17.91% | Brookfield |
| Price-to-Sales Ratio (TTM) | 1.24 | 2.70 | Brookfield |
| Enterprise Value | $455.84B | $44.38B | Brookfield |
| EV/Revenue Ratio | 5.45 | 2.44 | Ameriprise |
| Gross Profit Margin (TTM) | 38.73% | N/A | N/A |
| Revenue per Share (TTM) | $55 | $184 | Ameriprise |
| Earnings per Share (Diluted) | $0.29 | $29.42 | Ameriprise |
| Beta (Stock Volatility) | 2.19 | 1.22 | Ameriprise |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Brookfield vs Ameriprise Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Brookfield | -1.48% | -0.18% | -1.92% | 12.29% | 15.44% | 13.54% |
| Ameriprise | -1.10% | -2.13% | 0.18% | -1.18% | -4.65% | -4.29% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Brookfield | 41.64% | 60.70% | 144.81% | 299.39% | 691.04% | 1,062.63% |
| Ameriprise | 17.91% | 76.97% | 233.46% | 362.27% | 974.35% | 1,285.79% |
Performance & Financial Health Analysis: Brookfield vs Ameriprise
| Metric | BN | AMP |
|---|---|---|
| Market Information | ||
| Market Cap | $103.45B | $49.15B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 2,772,840 | 422,795 |
| 90 Day Avg. Volume | 2,169,097 | 460,865 |
| Last Close | $65.34 | $507.20 |
| 52 Week Range | $43.61 - $68.75 | $396.14 - $582.05 |
| % from 52W High | -4.96% | -12.86% |
| All-Time High | $68.75 (Jul 18, 2025) | $582.05 (Jan 27, 2025) |
| % from All-Time High | -4.96% | -12.86% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.22% | 0.02% |
| Quarterly Earnings Growth | -0.28% | 0.28% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.18% |
| Operating Margin (TTM) | 0.27% | 0.36% |
| Return on Equity (TTM) | 0.01% | 0.58% |
| Debt to Equity (MRQ) | 156.81 | 53.93 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $27.44 | $64.43 |
| Cash per Share (MRQ) | $8.32 | $84.34 |
| Operating Cash Flow (TTM) | $8.95B | $2.72B |
| Levered Free Cash Flow (TTM) | $-2,725,499,904 | $3.40B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.88% |
| Last 12-Month Dividend | N/A | $4.44 |
Valuation & Enterprise Metrics Analysis: Brookfield vs Ameriprise
| Metric | BN | AMP |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 232.59 | 17.70 |
| Forward P/E | 11.49 | 13.48 |
| PEG Ratio | 11.49 | 13.48 |
| Price to Sales (TTM) | 1.24 | 2.70 |
| Price to Book (MRQ) | 2.46 | 8.08 |
| Market Capitalization | ||
| Market Capitalization | $103.45B | $49.15B |
| Enterprise Value | $455.84B | $44.38B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.45 | 2.44 |
| Enterprise to EBITDA | 14.75 | N/A |
| Risk & Other Metrics | ||
| Beta | 2.19 | 1.22 |
| Book Value per Share (MRQ) | $27.44 | $64.43 |
Financial Statements Comparison: Brookfield vs Ameriprise
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BN | AMP |
|---|---|---|
| Revenue/Sales | $17.94B | $4.35B |
| Cost of Goods Sold | $11.00B | N/A |
| Gross Profit | $6.95B | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $4.48B | N/A |
| EBITDA | $8.23B | N/A |
| Pre-Tax Income | $598.00M | $687.00M |
| Income Tax | $383.00M | $104.00M |
| Net Income (Profit) | $215.00M | $583.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BN | AMP |
|---|---|---|
| Cash & Equivalents | $12.44B | $7.97B |
| Total Current Assets | $65.21B | N/A |
| Total Current Liabilities | $58.80B | N/A |
| Long-Term Debt | $245.86B | $5.98B |
| Total Shareholders Equity | $158.93B | $5.43B |
| Retained Earnings | N/A | $25.15B |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BN | AMP |
|---|---|---|
| Operating Cash Flow | $3.48B | $1.06B |
| Capital Expenditures | $-1.83B | $-36.00M |
| Free Cash Flow | $4.00M | $1.65B |
| Debt Repayment | $-20.53B | $-331.00M |
| Common Stock Repurchase | $-136.00M | $-730.00M |
Short Interest & Institutional Ownership Analysis
| Metric | BN | AMP |
|---|---|---|
| Shares Short | 15.19M | 1.69M |
| Short Ratio | 8.18 | 3.59 |
| Short % of Float | N/A | 0.02% |
| Average Daily Volume (10 Day) | 2,772,840 | 422,795 |
| Average Daily Volume (90 Day) | 2,169,097 | 460,865 |
| Shares Outstanding | 1.51B | 96.17M |
| Float Shares | 1.17B | 94.07M |
| % Held by Insiders | 0.18% | 0.00% |
| % Held by Institutions | 0.58% | 0.89% |
Dividend Analysis & Yield Comparison: Brookfield vs Ameriprise
| Metric | BN | AMP |
|---|---|---|
| Last 12-Month Dividend | N/A | $4.44 |
| Last 12-Month Dividend Yield | N/A | 0.88% |
| 3-Year Avg Annual Dividend | N/A | $5.02 |
| 3-Year Avg Dividend Yield | N/A | 0.36% |
| 3-Year Total Dividends | N/A | $15.07 |
| Ex-Dividend Date | N/A | Feb 10, 2025 |